メラノーマにおける抗腫瘍CD8+T細胞のフェノタイプ,特異性およびアビディティ
Giacomo Oliveira1,2, Kari Stromhaug1, Susan Klaeger3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature
|July 22, 2021
まとめ
腫瘍抗原の特異性は,メラノーマにおけるCD8+T細胞の表型を決定する. 腫瘍反応性T細胞は疲労を示し,非反応性細胞は記憶現象型を維持し,抗癌免疫に影響する.
科学分野:
- 免疫学
- 腫瘍学
- 細胞生物学
背景:
- T細胞受容体 (TCR) と腫瘍抗原の相互作用は,抗腫瘍免疫にとって極めて重要です.
- 腫瘍内のTCR特性とT細胞フェノタイプとの関連は不明である.
研究 の 目的:
- 腫瘍の特異性がメラノーマに浸透するCD8+T細胞の表型にどのように影響するか調査する.
- 腫瘍の微小環境におけるTCR特性とT細胞状態の関係を理解する.
主な方法:
- T細胞受容体 (TCR) の特異性をメラノーマ浸透性リンパ球のフェノタイプと関連付ける単細胞分析.
- 腫瘍抗原認識に関連したTCRアビディティ,結合親和性,クローン型持続性の評価.
主要な成果:
- メラノーマ反応性T細胞は,抗原型 (公的または新抗原) にかかわらず,主に枯渇したフェノタイプを示します.
- 非腫瘍反応性T細胞は,記憶現象型を示し,しばしばウイルス特異性を認識する.
- TCRアビディティは,標的の多量と,直接ペプチド-MHC結合親和性に相関する.
- 腫瘍内T細胞の枯渇はTCRのクローン型持続に悪影響を及ぼし,免疫チェックポイントの阻害に対する不十分な反応と相関しています.
結論:
- 腫瘍抗原の質と量はメラノーマの微小環境の中でT細胞の反応を大きく左右する.
- これらの抗原駆動型T細胞の特徴を理解することで,抗メラノーマTCRレパートリー特性に洞察を得ることができます.
- メラノーマの枯渇したT細胞フェノタイプは,腫瘍抗原の認識によって駆動され,治療反応に影響します.
さらに関連する動画
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
2.2K
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.6K
関連する概念動画
T Cell Activation and Clonal Selection
11.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
11.6K
Cytotoxic T Cells-mediated Immune Response
5.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.2K
Tumor Immunotherapy
779
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
779
Special Features of Adaptive Immunity
1.5K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.5K
